NANCY W PEACOCK MD NPI 1194751354

NPI Details

Nancy W Peacock, MD is a medical oncology internal medicine in Nashville, TN with 38 years of experience. The provider is an internist who specializes in the diagnosis and treatment of all types of cancer and other benign and malignant tumors. This specialist decides on and administers therapy for these malignancies as well as consults with surgeons and radiotherapists on other treatments for cancer. Nancy W Peacock, MD NPI is 1194751354. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a female.

Education
Medical School: UNIVERSITY OF MISSOURI, COLUMBIA SCHOOL OF MEDICINE
Graduation Year:1988

The provider's business location address is:

2004 HAYES ST STE 350
NASHVILLE, TN
ZIP 37203-650
Phone: (615) 312-3333
Fax: (615) 320-7091

The NPI 1194751354 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS:J0881)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Injection, pegfilgrastim, excludes biosimilar, 0.5 mg (HCPCS:J2506)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Injection, zoledronic acid, 1 mg (HCPCS:J3489)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
• Gammaglobulin (immune system protein) measurement (HCPCS:82784)
• Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a (HCPCS:G9678)
• Measurement of immunoglobulin light chains (HCPCS:83521)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Lactate dehydrogenase (enzyme) level (HCPCS:83615)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Protein measurement, serum (HCPCS:84165)
• Ferritin (blood protein) level (HCPCS:82728)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Iron level (HCPCS:83540)
• Immunologic analysis technique on serum (immunofixation) (HCPCS:86334)
• Iron binding capacity (HCPCS:83550)
• Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
• Thyroxine (thyroid chemical), free (HCPCS:84439)
• Magnesium level (HCPCS:83735)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Principal care management services for a single high-risk disease, first 30 minutes of clinical staff time directed by health care professional, per calendar month (HCPCS:99426)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 (HCPCS:86300)
• Injection, fosnetupitant 235 mg and palonosetron 0.25 mg (HCPCS:J1454)
• Application of on-body injector for under skin injection (HCPCS:96377)
• Infusion into a vein for hydration, each additional hour (HCPCS:96361)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• Red blood count, automated test (HCPCS:85045)
• Folic acid level, serum (HCPCS:82746)
• New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
• Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
• Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
• Administration of influenza virus vaccine (HCPCS:G0008)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage (HCPCS:90694)

The enumeration date for this NPI number is 6/22/2006 and was last updated on 7/21/2022.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.